×
About 553 results

AllMedicine Pseudomonas Aeruginosa Infections Center

Research & Reviews  259 results

International Consensus Guidelines for the Optimal Use of the Polymyxins
https://accpjournals.onlinelibrary.wiley.com/doi/full/10.1002/phar.2209

Feb 1st, 2019 - The polymyxin antibiotics colistin (polymyxin E) and polymyxin B became available in the 1950s and thus did not undergo contemporary drug development procedures. Their clinical use has recently resurged, assuming an important role as salvage thera...

Notes from the Field: Verona Integron-Encoded Metallo-β-Lactamase-Producing Carbapenem-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532950
MMWR. Morbidity and Mortality Weekly Report; Kracalik I, Ham C et. al.

May 23rd, 2019 - Notes from the Field: Verona Integron-Encoded Metallo-β-Lactamase-Producing Carbapenem-Resistant Pseudomonas aeruginosa Infections in U.S. Residents Associated with Invasive Medical Procedures in Mexico, 2015-2018.|2019|Kracalik I,Ham C,Smith AR,V...

An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700368
Antimicrobial Agents and Chemotherapy; Koeva M, Gutu AD et. al.

Sep 19th, 2017 - Bacterial persisters are a quasidormant subpopulation of cells that are tolerant to antibiotic treatment. The combination of the aminoglycoside tobramycin with fumarate as an antibacterial potentiator utilizes an antipersister strategy that is aim...

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848332
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Haidar G, Philips NJ et. al.

Oct 11th, 2017 - Data on the use of ceftolozane-tazobactam and emergence of ceftolozane-tazobactam resistance during multidrug resistant (MDR)-Pseudomonas aeruginosa infections are limited. We performed a retrospective study of 21 patients treated with ceftolozane...

Changes in antibiotic resistance in recurrent Pseudomonas aeruginosa infections of chro...
https://www.ncbi.nlm.nih.gov/pubmed/27792822
Ear, Nose, & Throat Journal; Song JJ, Lee BD et. al.

Oct 29th, 2016 - This study investigated the changes in antibiotic resistance in recurrent Pseudomonas aeruginosa infections in chronic suppurative otitis media (CSOM). Its aim was to provide a treatment strategy for P aeruginosa infections in CSOM for the prevent...

see more →

Guidelines  2 results

International Consensus Guidelines for the Optimal Use of the Polymyxins
https://accpjournals.onlinelibrary.wiley.com/doi/full/10.1002/phar.2209

Feb 1st, 2019 - The polymyxin antibiotics colistin (polymyxin E) and polymyxin B became available in the 1950s and thus did not undergo contemporary drug development procedures. Their clinical use has recently resurged, assuming an important role as salvage thera...

Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinet...
http://www.who.int/infection-prevention/publications/guidelines-cre/en/
WHO

Oct 31st, 2017 - Health care-associated infections (HAI) are one of the most common adverse events in care delivery. A large proportion are caused by antibiotic resistant organisms.

see more →

Clinicaltrials.gov  277 results

International Consensus Guidelines for the Optimal Use of the Polymyxins
https://accpjournals.onlinelibrary.wiley.com/doi/full/10.1002/phar.2209

Feb 1st, 2019 - The polymyxin antibiotics colistin (polymyxin E) and polymyxin B became available in the 1950s and thus did not undergo contemporary drug development procedures. Their clinical use has recently resurged, assuming an important role as salvage thera...

Guidelines for the prevention and control of carbapenem-resistant Enterobacteriaceae, Acinet...
http://www.who.int/infection-prevention/publications/guidelines-cre/en/
WHO

Oct 31st, 2017 - Health care-associated infections (HAI) are one of the most common adverse events in care delivery. A large proportion are caused by antibiotic resistant organisms.

Notes from the Field: Verona Integron-Encoded Metallo-β-Lactamase-Producing Carbapenem-...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532950
MMWR. Morbidity and Mortality Weekly Report; Kracalik I, Ham C et. al.

May 23rd, 2019 - Notes from the Field: Verona Integron-Encoded Metallo-β-Lactamase-Producing Carbapenem-Resistant Pseudomonas aeruginosa Infections in U.S. Residents Associated with Invasive Medical Procedures in Mexico, 2015-2018.|2019|Kracalik I,Ham C,Smith AR,V...

An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700368
Antimicrobial Agents and Chemotherapy; Koeva M, Gutu AD et. al.

Sep 19th, 2017 - Bacterial persisters are a quasidormant subpopulation of cells that are tolerant to antibiotic treatment. The combination of the aminoglycoside tobramycin with fumarate as an antibacterial potentiator utilizes an antipersister strategy that is aim...

Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5848332
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America; Haidar G, Philips NJ et. al.

Oct 11th, 2017 - Data on the use of ceftolozane-tazobactam and emergence of ceftolozane-tazobactam resistance during multidrug resistant (MDR)-Pseudomonas aeruginosa infections are limited. We performed a retrospective study of 21 patients treated with ceftolozane...

see more →

News  15 results

International Consensus Guidelines for the Optimal Use of the Polymyxins
https://accpjournals.onlinelibrary.wiley.com/doi/full/10.1002/phar.2209

Feb 1st, 2019 - The polymyxin antibiotics colistin (polymyxin E) and polymyxin B became available in the 1950s and thus did not undergo contemporary drug development procedures. Their clinical use has recently resurged, assuming an important role as salvage thera...

Filamentous bacteriophage linked to lung infections in patients with cystic fibrosis
https://www.mdedge.com/internalmedicine/article/199114/pulmonology/filamentous-bacteriophage-linked-lung-infections?channel=27970
Steve Cimino

Apr 18th, 2019 - Filamentous bacteriophage (Pf phage) may contribute to Pseudomonas aeruginosa infections in cystic fibrosis (CF) patients, according to a study of the prevalence and clinical relevance of Pf phage in two patient cohorts. CDC/ Janice Haney Carr A n.

Ceftolozane/Tazobactam for Pseudomonas aeruginosa Infections: Going Beyond the Package Insert
https://www.medscape.com/viewarticle/858169

Feb 8th, 2016 - 'These Lungs Need Something' A 26-year-old woman has cystic fibrosis, which is progressing. Without a lung transplant, it is doubtful she will make it to age 30. Her respiratory sample culture results are all too familiar to those who work in mode...

FDA Panel Gives High Sign for New CF Drug
https://www.medpagetoday.com/pulmonology/cysticfibrosis/34590

Sep 5th, 2012 - An FDA advisory committee voted 13-1 to recommend approval for a dry-powder formulation of tobramycin to treat pulmonary Pseudomonas aeruginosa infections in cystic fibrosis patients. Although agency staff had questioned the product's efficacy and...

Verona Integron-Encoded Metallo-β-Lactamase–Producing Carbapenem-Resistant Pseudomonas Aeruginosa Infections in U.S. Residents Associated With Invasive Medical Procedures in Mexico, 2015–2018
https://www.medscape.com/viewarticle/913569

Verona integron-encoded metallo-β-lactamase–producing carbapenem-resistant Pseudomonas aeruginosa (VIM-CRPA) and other carbapenemase-producing organisms represent an emerging U.S. public health threat because of high levels of antibiotic resistanc...

see more →